glp-1 semaglutide Types of Medications for Weight Loss: Differences, Uses & Safety GLP-1 Semaglutide Rx | FancyMeds

In a post-hoc analysis of AWARD-11, the effect of dulaglutide treatment was associated with consistent safety and efficacy patterns regardless of their renal function status at baseline, with no more gastrointestinal adverse effects nor hypoglycemic events in those subjects with lower renal function [95]

Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment

Retatrutide hits GLP-1, GIP, and glucagon receptors simultaneously

Similarly, several nonalcoholic fatty liver diseases (NAFLDs), IBDs, hepatocellular carcinoma, cardiovascular diseases (CVDs), alcoholic liver disease (ALD), chronic kidney diseases (CKDs), and cirrhosis are associated with the gut microbiota and its metabolites (Hsu et al., 2020

Across all GLP-1 medications, 12-month persistence (still taking the medication at one year) ranges from 38% to 56% depending on the study and population (Wilding et al., Diabetes Obes Metab 2023)

In addition, it will be of interest to understand whether the carnitine shuttle plays a role in compensating for ACLY and ACSS2 under conditions such as high fat diet, in which both enzymes are suppressed in adipose tissue 43